Topic

Neuroscience

6 articles on Neuroscience, written by Shotlee and medically reviewed for clinical accuracy.

GLP-1 Drugs for Alcohol Use Disorder: The Future of Addiction Treatment?
Medical Innovation

GLP-1 Drugs for Alcohol Use Disorder: The Future of Addiction Treatment?

GLP-1 receptor agonists, widely known for their efficacy in weight management and type 2 diabetes, are showing remarkable promise in addressing Alcohol Use Disorder (AUD). Emerging research suggests these injectable therapies may fundamentally alter the brain's reward pathways, offering a novel pharmaceutical path for those struggling with heavy drinking.

6 min read
Eli Lilly 150 Years: AI, GLP-1 Advances & Future of Weight Loss
Health Technology

Eli Lilly 150 Years: AI, GLP-1 Advances & Future of Weight Loss

Eli Lilly celebrates 150 years with a focus on AI-driven manufacturing, new GLP-1 oral therapies, and expanded neuroscience research, signaling a major shift in pharmaceutical innovation.

8 min read
AI Startup Acquires Parkinson's Cell Therapy from Ozempic Maker
Health & Wellness

AI Startup Acquires Parkinson's Cell Therapy from Ozempic Maker

Mark Zuckerberg-backed AI startup Cellular Intelligence has acquired global rights to STEM-PD, an experimental Parkinson's disease cell therapy developed by Novo Nordisk, the pharmaceutical giant behind Ozempic and Wegovy. This strategic move signals a new era for AI in accelerating complex therapeutic development.

7 min read
GLP-1 Drugs: New Insights into How They Suppress Cravings
Weight Management

GLP-1 Drugs: New Insights into How They Suppress Cravings

A groundbreaking NIH-funded study reveals that emerging GLP-1 weight-loss drugs, including oral options like orforglipron, work by targeting a specific brain reward pathway, distinct from their appetite-suppressing effects. This discovery opens new avenues for understanding and treating conditions beyond weight management.

6 min read
Antimicrobial Peptides: A New Link to Neurodegenerative and Amyloid Diseases
Medical Research

Antimicrobial Peptides: A New Link to Neurodegenerative and Amyloid Diseases

Discover the groundbreaking research linking antimicrobial peptides (AMPs) to neurodegenerative and amyloid diseases. This article delves into the shared mechanisms, bidirectional feedback loops, and potential new therapeutic strategies emerging from this exciting field.

8 min read
Semax Peptide: Research on Neuroprotection, Inflammation, and Vascular Effects
Medical Research

Semax Peptide: Research on Neuroprotection, Inflammation, and Vascular Effects

Semax, a synthetic heptapeptide, has demonstrated neuroregulatory, neuroprotective, and immunomodulating properties in various research models. This article examines its biochemical characteristics, possible effects on gene expression, interactions with neurotransmitter systems, vascular modulation, metal binding, and utility in ischemia-reperfusion injury studies.

5 min read